Despite clear diagnostic distinctions, schizophrenia and autism share symptoms on several dimensions. Recent research has suggested the two disorders overlap in etiology, particularly with respect to inherited and noninherited genetic factors. Studying the relationship between psychotic-like and autistic-like symptoms in risk groups such as 22q11 deletion syndrome (22q11DS) and schizotypal personality disorder (SPD) has the potential to shed light on such etiologic factors; thus, the current study examined prodromal symptoms and autistic features in samples of 22q11DS and SPD subjects using standardized diagnostic measures, including the Structured Interview for Prodromal Symptoms (SIPS) and the Autism Diagnostic Inventory-Revised (ADI-R). Results showed that SPD subjects manifested significantly more severe childhood and current social as well as stereotypic autistic features, as well as more severe positive prodromal symptoms. The two groups did not differ on negative, disorganized, or general prodromal symptoms, but were distinguishable based on correlations between prodromal and autistic features; the relationships between childhood autistic features and current prodromal symptoms were stronger for the SPD group. The results suggest that childhood autistic features are less continuous with subsequent prodromal signs in 22q11DS patients relative to those with SPD, and the findings highlight the importance of studying the overlap in diagnostic phenomenology in groups at risk for developing psychosis and/or autism.
Autism and schizophrenia are considered two of the most debilitating psychiatric disorders. While contemporary diagnostic systems have made the boundaries between the two disorders more explicit, it is now assumed that there are spectra of autistic and schizophrenia-related disorders that have considerable overlap and comorbidity with respect to symptomology. For example, studies have found that individuals with either autism-spectrum disorders (ASD) or schizophrenia-spectrum disorders (SSD) often exhibit symptoms or characteristics of the other disorder (Konstantareas & Hewitt, 2001; Nylander & Gillberg, 2001; Sheitman, Bodfish, & Carmel, 2004) . Further, Asperger's disorder, a milder ASD, and schizotypal personality disorder (SPD), a milder SSD, both involve social deficits and odd behaviors, as well as difficulties with emotional functioning and subtle motor abnormalities (Raine, 2006; Weiss & Harris, 2001) .
Research focusing on the autism-schizophrenia overlap has turned to investigating individuals with these milder autistic-or schizophrenia-spectrum syndromes, which allows for study of similarities across the two disorders without the confounding effects of psychotropic medications or chronic, severe illness. Results have demonstrated that adolescents with SPD show more severe autistic-like behaviors compared to nonpsychiatric control participants (Esterberg, Trotman, Brasfield, Compton, & Walker, 2008) , and that schizotypal features are associated with features of Asperger's disorder in nonclinical individuals (Hurst, NelsonGray, Mitchell, & Kwapil, 2007) . Furthermore, Asperger's-related social and communication deficits correlate strongly with schizotypal-related interpersonal deficits and disorganized symptoms, respectively (Hurst et al., 2007) . Others have demonstrated that adolescents with ASD were more likely to also meet criteria for SPD, and they displayed more severe positive, negative, and disorganized schizotypal symptoms relative to typically developing controls (Barneveld et al., 2010) .
Early research in this area hypothesized a common etiology between schizophrenia and autism as an explanation for the similarities in clinical presentation across the two disorders (Bender, 1947) . Crespi and Badcock (2008) suggest a continuum between autism and psychosis, with autism and underdeveloped social cognition at one extreme, normal or balanced cognition at the center of the continuum, and schizophrenia and hyper-developed social cognition at the other extreme. In line with this theory, they note that autism and psychosis, both disorders of the social brain, are heterogeneous but also convergent, and hypothesize that differences in neurodevelopmental dysregulation (i.e., accelerated neurodevelopment in autism, slowed neurodevelopment in schizophrenia) result in phenotypic similarities in behavioral, social, and cognitive functioning (Crespi & Badcock, 2008) . Molecular genetic studies have suggested alternative explanations for the similarities between schizophrenia and autism. Cook and Scherer (2008) conclude that research on copy number variants (CNVs, which are insertions, duplications, deletions, or allelic rearrangements of particular genes) has demonstrated support for a variable expressivity model: common genes may account for the development of different psychiatric disorders. Several researchers have demonstrated that CNVs are involved in the development of both autism and schizophrenia (Awadalla et al., 2010; Kusenda & Sebat, 2008; Ingason et al., 2011; Moreno-De-Luca & Cubells, 2011; Stefansson et al., 2008) . While this may simply be due to chance, it is possible that the genes involved in both disorders show variable expressivity (i.e., genes for autism also confer susceptibility to milder forms of autism or related disorders) or are pleiotropic, meaning that they exert multiple effects. This is only one potential etiological explanation for the similarities between the two spectra.
With the possibility of a common genetic etiology in mind, the associations between the milder ends of the autism and schizophrenia spectra point to the notion of studying genomic disorders associated with both spectra. Of potential interest is the 22q11.2 deletion syndrome (2211qDS), a genetic disorder that shows variable physical phenotypes, including heart defects, cleft palate, immune deficiencies, skeletal abnormalities, and minor facial anomalies. Occurring in 1 out of 4,000 births (Wilson et al., 1994) , 22q11DS, one of the most common chromosomal disorders, is caused most commonly by deletions of approximately three million base pairs on one copy of the 22nd chromosome. Only about 10% of 22q11DS cases are inherited; the majority of cases arise de novo due to nonallelic homologous recombination during the meiotic divisions of gametogenesis.
Individuals with 22q11DS are also at increased risk for schizophrenia and autism, as well as other psychiatric disorders such as ADHD (Jolin et al., 2009) , depression (Antshel et al., 2006) , and bipolar disorder (Papolos et al., 1996) . Baker and Skuse (2005) found that nearly 80% of a 22q11DS sample met criteria for one or more DSM-IV psychiatric disorders, compared to only 21% of controls; 22q11DS adolescents showed significantly more severe schizotypal symptoms relative to the control sample. Stoddard, Niendam, Hendren, Carter, and Simon (2010) demonstrated that nonpsychotic adolescents with 22q11DS experience moderate to severe levels of prodromal symptoms, which are most reliably associated with increased clinical risk for schizophrenia (Cannon et al., 2008) . Relatedly, others have found that approximately 30% of individuals with 22q11DS develop schizophrenia (Antshel et al., 2010; Gothelf et al., 2007; Kates et al., 2011) , with even more individuals experiencing more broadly defined psychotic disorders (Basset & Chow, 2008) . This is compared to a 1-2% risk for developing schizophrenia in the general, non22q11DS population (Jablensky, 1997) . Antshel et al. (2007) found that 42% of their youth sample with 22q11DS met criteria for an ASD, with eight of the 41 children meeting criteria for autism. Vorstman et al. (2006) found that 50% of a sample of 22q11DS children and adolescents were diagnosed with an ASD, and over 11% were diagnosed with a psychotic disorder.
In summary, the above-reviewed findings suggest that autism and schizophrenia have important similarities in clinical presentation and show considerable phenomenological overlap, especially at the milder ends of the spectra of disorders. In particular, individuals with SPD tend to exhibit more severe autistic-like features when compared to nonpsychiatric controls, individuals with ASD show more severe schizotypal symptoms relative to normal individuals, and schizotypal symptoms tend to covary with milder ASD symptoms. Both neurodevelopmental dysregulation and commonalities in genetic etiology have been hypothesized to account for these similarities; evidence for the involvement of particular CNVs in the development of both schizophrenia and autism, as well as the risk for both disorders in the genetic disorder 22q11DS provide some support for these etiological hypotheses.
These trends suggest that continued studies of the characteristics of groups at risk for SSD and ASD may be fruitful, and a natural next step could be comparing clinical-and genetic-risk groups. In particular, it is of interest to know whether schizophrenia-related (i.e., schizotypal or prodromal) and autistic-spectrum symptoms manifested by unique risk groups differ with respect to severity, pattern, or developmental course. Such comparisons have the potential to shed light on potential etiologic explanations for the autism/schizophrenia overlap. To our knowledge, there have been no studies comparing the nature and severity of either schizophrenia-or autistic-spectrum symptoms in groups that present with unique levels of risk (i.e., clinical risk vs. genetic risk) for either schizophrenia or autism. In order to address this gap in our understanding of these important risk groups, the present study uses standardized diagnostic measures to examine both schizophrenia-and autistic-spectrum symptoms in: (a) individuals with 22q11DS, (b) adolescents with SPD, and (c) nonpsychiatric control adolescents. The authors hypothesize that: (a) both adolescents with SPD and those with 22q11DS would show more severe autistic-spectrum symptoms than healthy control participants, (b) autistic-spectrum symptoms would positively correlate with prodromal symptoms in both SPD and 22q11DS participants, and (c) both adolescents with SPD and those with 22q11DS would show more severe prodromal symptoms when compared to healthy control participants.
Method
Participants SPD and control sample.
Participants in the SPD and healthy control samples consist of 77 adolescents ranging from 11 to 18 years of age. These adolescents were drawn from a large, longitudinal research study on biological and behavioral markers of SPD. Participants were recruited through announcements aimed at parents and clinicians, and through the Emory University Research Participant Registry. At baseline, diagnostic assessments were administered, and participants were classified into two diagnostic categories: SPD (n ϭ 30; 28.6% of overall sample) or healthy controls (n ϭ 47; 44.8% of overall sample). Exclusion criteria for both the SPD and healthy control groups were a neurological disorder and any Axis I disorder, including psychotic disorders, autism, and substance use disorders. 22q11DS sample. Participants were ascertained in reverseage order from a case registry of individuals diagnosed with 22q11DS. The case registry has been maintained at Children's Health care of Atlanta since 1996. Fluorescence In Situ Hybridization (FISH) was utilized to confirm the presence of the 22q11.2 deletion in each participant. Each individual was initially referred for FISH testing as either a child or adolescent, due to the presence of heart defects, speech and language difficulties, and/or immunological problems. Participants and their caregivers were interviewed at the Emory University 22q11DS clinic, a collaborative treatment and research center maintained by researchers and physicians from Children's Health care of Atlanta and from the departments of Human Genetics and Psychiatry and Behavioral Sciences at Emory University. A total of 28 (26.7% of overall sample) individuals with 22q11DS ranging in age from 14 to 29 years were included in the current sample. Those subjects from the registry that were diagnosed with a neurological disorder or any Axis I disorder, including psychotic disorders, autism, and substance use disorders, were not included in the present sample.
Procedure
Following the telephone-screening interview, individuals who met criteria for inclusion in the study were invited for an initial 4-hr research assessment. All research subjects provided informed consent; parents of subjects between the ages of 12 and 17 years provided parental informed consent. Graduate students, mastersor doctoral-level clinicians, conducted all assessments. Each assessment included a battery of diagnostic measures that were administered to each subject, and collateral reports were collected from parents or guardians. Each research subject was interviewed using the diagnostic measures, and assessment of childhood and current autistic features was conducted via structured interview (ADI-R) with the parent or guardian.
Measures
The Structured Interview for DSM-IV Personality (SIDP-IV; Pfohl et al., 1997) , a semistructured interview that assesses DSM-IV Axis II criteria using questions about relationships, interests and activities, and emotions, was used to determine the presence of SPD. Interviewers rate personality disorder criteria on a scale from 0 (not present) to 3 (strongly present). This measure emphasizes trait functioning, states, moods, or behaviors induced by an external stimulus. The semistructured interview, taking between 60 and 90 minutes to complete, includes a portion of the measure that allows interviewers to rate clinical observations of each participant. Because of the one-to-one correlation between the SIDP-IV and the DSM-IV criteria, it is assumed to be a valid measure of personality disorders.
The Structured Clinical Interview for DSM-IV (SCID-I; APA, 2000) . was used to screen for Axis I disorders, and participants meeting criteria for any Axis I disorder were excluded from the study. The Structured Interview for Prodromal Syndromes (SIPS; McGlashan et al., 2001 ), a semistructured diagnostic interview, was used to measure the severity of prodromal symptoms. The SIPS includes 29 interviewer-rated items that measure positive symptoms (e.g., unusual thought content, persecutory ideas, and grandiosity), negative symptoms (e.g., social isolation, avolition, decreased expression and experience of emotions, decreased ideational richness, and deterioration of role functioning), disorganized symptoms (e.g., odd behavior/appearance, bizarre thinking, focus/attention problems, and impairment in personal hygiene), and general symptoms (e.g., sleep disturbance, dysphoric mood, motor disturbances, and impaired stress tolerance). Scores of 0 -2 are considered to be nonprodromal, scores falling between 3 and 5 are thought to be in the prodromal category, and scores of 6 are in the psychotic category (Miller et al., 2002) . The Autism Diagnostic Interview-Revised (ADI-R; Lord, Rutter, & Le Couteur, 1994 ) was used to assess childhood and current levels of functioning as they related to features of autistic-spectrum disorders. For the purposes of this study, only selected items were analyzed: social interaction (19 items), communication and language (four items), and repetitive, stereotyped interests and behaviors (11 items). An interviewer questioned the parent/guardian about the child's current level of functioning with respect to the autistic feature and the child's level of functioning during early childhood, age range from birth through toddlerhood. A trained clinician administered the ADI-R interview to the parent of the participant, and responses were scored based on the caregiver's description of the subject's childhood and current behavior. Each item receives a score ranging from 0 to 3, with 0 indicating the behavior in question was/is not present, 1 indicating the behavior in question is present in an abnormal form (but not sufficiently severe or frequent to meet the criteria for a 2), 2 indicating the presence of definite abnormal behavior, and 3 indicating the presence of extreme severity of the specified behavior (Lord et al., 1994) . While the ADI-R allows for the option to use an algorithm for the diagnosis of autism, this algorithm was not used in the present study given the focus on severity of autistic-like features in individuals without an ASD.
Data Analysis
Sociodemographic and clinical information for each diagnostic group was determined using basic descriptive and frequency analyses in the statistical data analysis program Statistical Package for the Social Sciences, version 18.0 (SPSS 18.0). Analysis of variance (ANOVA) was used to determine sociodemographic differences between the three diagnostic groups and to identify potential covariates for the more complex analyses. Finally, constants were added and transformations were applied to non-normal, continuous clinical variables to satisfy assumptions of parametric statistical tests. With the exception of the item analyses, the three ADI-R domains of communication, social interaction, and repetitive interests and behaviors and the four SIPS domains of positive, negative, disorganized, and general symptoms were utilized for all analyses.
Multivariate Analysis of Covariance (MANCOVA) was used to compare the three diagnostic groups on childhood autistic features, current autistic features, and current prodromal symptoms using sex as an additional independent variable while controlling for age and race. Three MANCOVA analyses were conducted: (a) childhood autistic features in all three domains (communication, social interaction, and repetitive interests and behaviors); (b) current autistic features in all three domains; and (c) current prodromal symptoms in all four domains. To maintain statistical power, planned comparisons based on a priori hypotheses were used to follow up on significant omnibus tests. Given the use of planned comparisons, corrections for multiple comparisons were not utilized. Partial eta squared (partial 2 ) was used as an effect size indicator, with the following conventions used: small ϭ 0.01; medium ϭ 0.06; large ϭ 0.14 (Kittler, Menard, & Phillips, 2007) .
Finally, Pearson's product-moment correlation r was used to examine the relationship between childhood and current autistic features and current prodromal symptoms within the SPD and 22q11DS diagnostic groups. An r-to-z transformation was conducted to convert the r correlation for each group (representing the relationship between each set of clinical variables) into a standardized measure, and these standardized correlations were compared to test for differences between the two diagnostic groups with respect to the strength of the correlations. Corrections for multiple comparisons were not used.
Results
Participants were 30 individuals with SPD, 28 individuals with 22q11DS, and 47 healthy, nonpsychiatric control participants. Descriptive characteristics of the clinical variables as well as sociodemographic information according to diagnostic group are provided in Table 1 . As shown, there were 48 (45.7%) females and over half the sample was European American (n ϭ 70, 66.7%). Across the entire sample, the ages of study participants ranged from 11 to 29 years, with a mean age of 15.5 Ϯ 3.5 years. The three groups differed significantly on age, F ϭ 39.5, p Ͻ .001, with 22q11DS participants being significantly older than SPD and control participants, as well as race distribution ( 2 ϭ 22.5, p Ͻ .01), with a greater proportion of African American participants in the control sample. Subsequent analyses included age and selfidentified race as covariates.
Sex differences were observed for several of the clinical variables. Across all groups, males were rated more severely on negative (t ϭ 2.31, p Ͻ .05) and disorganized (t ϭ 2.23, p Ͻ .05) prodromal symptoms relative to females. Males also scored more severely on childhood repetitive interests and behaviors (t ϭ 2.09, p Ͻ .05), current social interaction (t ϭ 2.26, p Ͻ .05), and current repetitive interests and behaviors (t ϭ 2.00, p Ͻ .05). This pattern of findings is consistent with previous reports of more pronounced negative (Leung & Chue, 2000; Thorup et al., 2007) and autistic (Lingam et al., 2003; Scott, Baron-Cohen, Bolton, & Brayne, 2002 ) symptoms in males. Given these significant differences, sex was included as an additional independent variable to investigate potential interactions.
Regarding childhood autistic features, Wilk's Lamda multivariate results supported an overall significant difference among the three diagnostic groups (F ϭ 9.39, df ϭ 6, 174, p Ͻ .001), with a large effect size for the difference between groups (partial 2 ϭ 0.25). There was no significant main effect of sex nor was there a significant interaction between diagnostic group and sex. Univariate results revealed that childhood communication, F ϭ 6.75, p Ͻ .01, childhood social functioning, F ϭ 13.89, p Ͻ .001, and childhood repetitive interests and behaviors, F ϭ 5.92, p Ͻ .01 significantly differed among the three diagnostic groups (see Table 2 ).
Planned comparisons showed that 22q11DS participants had more severe childhood communication scores relative to both control, t ϭ 5.13, p Ͻ .001 and to SPD participants, t ϭ 3.59, p Ͻ .01. For childhood social interaction, 22q11DS participants did not differ from control participants, but SPD participants had significantly more severe scores relative to both control, t ϭ 5.12, p Ͻ .001 and 22q11DS participants, t ϭ 3.83, p Ͻ .001. Finally, 22q11DS participants did not differ from control participants in childhood repetitive interests and behaviors but, again, SPD participants scored significantly higher than controls, t ϭ 2.89, p Ͻ .01 and 22q11DS participants, t ϭ 2.17, p Ͻ .05. These results are depicted in Figure 1 .
With respect to the severity of current autistic features, multivariate tests showed an overall significant difference among the three diagnostic groups (F ϭ 8.57, df ϭ 6, 184, p Ͻ .001), with a large effect size for the difference between groups (partial 2 ϭ 0.22). There was no significant main effect of sex nor was there a significant interaction between diagnostic group and sex. Univariate analyses showed that deficits in current communication, F ϭ 10.56, p Ͻ .001, social interaction, F ϭ 12.72, p Ͻ .001, and 1.3 Ϯ 0.9 0.5 Ϯ 0.6 1.5 Ϯ 0. repetitive interests and behaviors, F ϭ 6.43, p Ͻ .01 significantly differed among the three groups (see Table 3 ). Planned comparisons showed that 22q11DS participants showed more current communication deficits relative to control, t ϭ 3.92, p Ͻ .001 and SPD participants, t ϭ 3.96, p Ͻ .001. For current social interaction, 22q11DS participants did not differ from control participants, but SPD participants had significantly more severe scores relative to both control, t ϭ Figure 2 . Correlational analyses examined the relationships between childhood and current autistic features and current prodromal Table 4 ). Planned comparisons showed that 22q11DS participants showed more severe positive symptoms relative to controls, t ϭ 7.38, p Ͻ .001, and SPD participants showed more severe positive symptoms relative to controls, t ϭ 13.01, p Ͻ .001 and 22q11DS participants, t ϭ 4.88, p Ͻ .001. Participants with 22q11DS, t ϭ 9.13, p Ͻ .001 and SPD participants, t ϭ 6.09, p Ͻ .001 scored more severely relative to controls on negative symptoms, but 22q11DS participants did not differ from SPD participants, t ϭ 1.27, ns. Participants with 22q11DS, t ϭ 7.47, p Ͻ .001 and SPD participants, t ϭ 7.93, p Ͻ .001 showed more severe disorganized symptoms relative to control participants, but 22q11DS participants did not differ significantly from SPD participants, t ϭ 0.73, ns. Finally, 22q11DS participants, t ϭ 7.27, p Ͻ .001 and SPD participants, t ϭ 6.32, p Ͻ .001 showed significantly more severe general symptoms relative to controls, but 22q11DS participants again did not differ from SPD participants, t ϭ 0.92, ns. These results are depicted in Figure 3 .
Discussion
Studies in the area of overlap between autism and schizophrenia have revealed interesting results on the relationships between the two spectra of disorders. The present study sought to further investigate this relationship by examining: (a) similarities and differences in both autistic features and prodromal symptoms, and (b) potential differences in the relationship between autistic features and prodromal symptoms in a sample of SPD adolescents and a sample of individuals with 22q11DS. Both groups show an increased risk of developing a psychotic disorder, as well as an elevated incidence of either autistic-like behaviors or ASD. Comparing these two groups has the potential to shed light on the nature and origin of these overlapping syndromes. The first aim of the present study was to contrast the two risk groups with respect to childhood and current autistic features. As described above, previous research has demonstrated a relationship between SPD, schizotypal symptoms, and autistic-spectrum symptoms across both psychiatric and normal populations (Barneveld et al., 2010; Esterberg et al., 2008; Hurst et al., 2007) . Research also suggests that individuals with 22q11DS show more severe autistic features and are at heightened risk for developing autisticspectrum disorders relative to healthy controls (Niklasson, Rasmussen, Oskarsdottir, & Gillberg, 2009; Vorstman et al., 2006) . Given these findings, it was hypothesized that both SPD and 22q11DS individuals would display more severe autistic features relative to controls.
This hypothesis was only partially confirmed. Individuals with 22q11DS showed significantly more severe autistic features relative to both SPD and control participants only in the domain of communication. This was observed for both childhood and current communication deficits. This finding could be partially attributable to the mouth and palate malformations that are common in individuals with 22q11DS, which may impair communication abilities in the areas of articulation and pronunciation. Regardless of the degree to which anatomic features contribute to communication deficits, the present results suggest that communication skills might be particularly important targets for early intervention in children with 22q11DS.
The SPD participants showed the greatest severity on the other two ADI-R domains: social interaction and repetitive interests/ behaviors. In contrast, the 22q11DS group did not significantly differ from the healthy control participants in these two domains, which is noteworthy in light of the documented high risk for ASD in 22q11DS patients. Also of interest was the more pronounced level of social deficits in the SPD group. It is particularly remarkable that SPD individuals were rated by parents as showing more severe childhood social impairments and repetitive interests/ behaviors relative to participants with 22q11DS, given their similar increased risk for ASD when compared to individuals with SPD. These diagnostic group differences indicate that the ADI-R might be tapping into childhood behavioral deficits that are more common or prevalent in SPD youth. Further, it may be that the behavioral features measured by the ADI-R in the SPD sample differ from those being measured by the ADI-R in the 22q11DS sample. Finally, differences in recruitment strategies may have contributed to possible bias in selecting for greater psychopathology in the SPD group. The second aim of the study was to examine associations between autistic features and prodromal symptoms. Our findings on these associations may shed additional light on the above findings on group differences in autistic features. We hypothesized that autistic features would be positively correlated with prodromal symptoms across both samples. Previous research has suggested that ASD features tend to covary with schizotypal symptoms, with findings on positive associations between Asperger's-related social deficits and SPD-related interpersonal deficits, and between Asperger's-related communication deficits and SPD-related disorganization (Hurst et al., 2007) . Our findings demonstrated a positive association between communication deficits and positive prodromal symptoms, but only in the 22q11DS sample. Additionally, current social interaction deficits and negative prodromal symptoms were positively correlated. However, autistic features did not correlate with disorganized symptoms, and they were negatively correlated with general symptoms.
There were several notable findings with respect to the correlational analyses. Of most interest was that the direction of the relationship between childhood communication deficits and general symptoms differed between SPD and 22q11DS participants. In 22q11DS participants, communication deficits were associated with less general symptoms, whereas in SPD participants these deficits were related to more general symptoms. It is possible that communication deficits led to difficulties in reporting on general prodromal symptoms, but it is not clear why this association would be different for SPD individuals. Second, the relationship between childhood social interaction deficits and general prodromal symptoms was significantly stronger in SPD participants relative to 22q11DS participants. Finally, positive associations between childhood autistic features and current prodromal symptoms, or childhood impairment and current functioning, were found only in the SPD sample. Despite our findings that SPD and 22q11DS individuals are comparable with respect to severity of current negative, disorganized and general prodromal symptoms, continuity between childhood impairment and current functioning is only observed for the SPD group.
One possible explanation for the significant association between the childhood ADI-R ratings and current SIPS ratings in the SPD sample may involve the pathogenic processes associated with 22q11DS. Recent evidence suggests a more pronounced developmental change over time in the behavioral deficits associated with 22q11DS relative to the general population and other groups at risk for psychosis. For example, a recent study of 22q11DS subjects revealed a significant inverse correlation between age and cognitive function, indicating that 22q11DS subjects manifest a pronounced decline (p Ͻ .001) between ages 1 and 35 years (Niklasson & Gillberg, 2010) . Consistent with these neurocognitive findings, another study revealed that 22q11DS subjects showed significantly more age-related brain-volume decline; preadolescent 22q11DS patients showed larger prefrontal thickness than agematched controls, whereas older adolescent 22q11DS subjects showed more dramatic loss in cortical thickness (Schaer et al., 2009) . Furthermore, Shashi et al. (2010) demonstrated that children with 22q11DS show volumetric reductions in gray matter in the frontal cortices, the cingulate gyrus, and the cerebellum that related to poorer executive functioning. There is no comparable evidence of pronounced developmental decline in cognitive abilities or brain structure in SPD patients. Although some metaanalyses suggest a subtle decline in cognitive function and gray matter volume prior to the onset of psychosis in non22q11DS samples Smieskova et al., 2010) , the change is not consistently observed .
Thus, the limited associations between childhood deficits and current prodromal symptoms in the 22q11DS group may reflect a greater developmental discontinuity. While the source of this discontinuity is unknown, it has been suggested that developmental changes in gene expression are modifying the phenotype of 22q11DS with age, resulting in greater developmental variability (Amati et al., 2007) . However, this is only one hypothesis for these findings. The differences between the two risk groups may be due to other factors such as: (a) selection bias, or (b) exclusion of more severe psychopathology in the two samples, which led to decreased variance in symptoms and impacted our ability to detect true associations between childhood and current functioning.
The final aim of the study was to investigate differences in the severity of prodromal symptoms between SPD and 22q11DS individuals. It was hypothesized that individuals with both SPD and 22q11DS participants would show greater severity of prodromal symptoms relative to healthy controls. The present results are generally consistent with this hypothesis in that SPD and 22q11DS participants showed more severe symptoms in all prodromal symptom domains relative to control participants, yet they did not differ from each other in the severity of negative, disorganized, or general prodromal symptoms. However, SPD individuals exhibited more severe positive prodromal symptoms, which map onto the positive symptoms of schizophrenia (i.e., hallucinations, delusions, and disorganization).
There are several potential explanations for the difference in positive prodromal symptoms between the two risk groups. The first, and likely most plausible, is the differences in recruitment strategies between the two samples. As stated above, the SPD sample was recruited based on the presence of "positive" signs of SPD such as perceptual difficulties, odd beliefs, and trouble communicating. The 22q11DS sample was identified solely on the basis of their chromosomal abnormality. Thus, selection may have been biased toward recruiting an SPD sample with more positive prodromal symptomology. Alternatively, it is possible that the present SPD sample is at greater risk for psychosis relative to the 22q11DS sample herein. The SPD sample has been studied over a 5-year period and approximately 28% of these adolescents with SPD developed a psychotic disorder during the follow-up period (Tessner, Mittal, & Walker, 2011) . The 22q11DS sample, however, has not been followed up, so the percentage of the sample that will go on to develop psychosis is unknown.
Alternatively, it is possible that the present findings reflect a unique prodromal symptom profile in 22q11DS in that they may show less pronounced positive prodromal symptoms relative to SPD subjects. Another study from our laboratory using an agematched subset of the current sample found that SPD and 22q11DS individuals only differed on one negative prodromal symptom (i.e., decreased ideational richness) and did not differ on positive prodromal symptoms (Shapiro, Cubells, Ousley, Rockers, & Walker, 2011) . However, there have been no previous studies comparing risk groups on prodromal symptoms, and the limited available research on diagnosed patients shows the 22q11DS-schizophrenia does not differ from non22q11DS-schizophrenia with respect to positive symptoms (Bassett et al., 2003; Murphy, Jones, & Owen, 1999) . However, one recent study on prodromal symptoms in adolescents with 22q11DS demonstrated that greater percentages of adolescents show more severe negative, disorganized, and general prodromal symptoms relative to positive prodromal symptoms (Stoddard et al., 2010) . The findings suggest that it is the negative, disorganized, and general prodromal symptoms that are more prevalent in the period preceding possible conversion to psychosis in 22q11DS.
In summary, the findings herein suggest that the prodromal symptom profile is strikingly similar across SPD and 22q11DS individuals, with some notable differences in positive prodromal symptom presentation that may be due to true differences or possible selection bias. Further, despite similar propensities toward exhibiting more severe autistic-like behaviors, SPD and 22q11DS can be differentiated from one another on the basis of three deficit domains related to autism.
Research on inherited and noninherited genetic factors provides some explanation for the similarities between SPD and 22q11DS found in the current study. For example, several studies of familial risk have revealed a heightened rate of schizophrenia spectrum disorders in family members of patients with autism. Larsson et al. (2005) , using a case-control design in Denmark, found that risk for developing autism was associated with parental history of psychopathology, particularly schizophrenia-like psychosis. Another recent study linked data from multiple Swedish medical registries and found that schizophrenia is more common in the fathers and mothers of autistic probands than in parents of controls, providing support for familial aggregation of autism and schizophrenia (Daniels et al., 2008) . Thus, some heritable genetic vulnerabilities may confer risk for both spectra of disorders.
Additionally, emerging evidence from genome-wide association studies (GWAS) suggests that common pathways contribute to risk for autism and schizophrenia, which also provides support for the similarities in deficits seen across both SSD and ASD. In particular, multiple GWAS have implicated a common set of CNVs in ASD and schizophrenia (Bassett, Scherer, & Brzustowicz, 2010; Kusenda & Sebat, 2008; Moreno-De-Luca & Cubells, 2011; Stefansson et al., 2008) . Cook and Scherer (2008) posit that rare CNVs account for a portion of the genetic predisposition to disorders such as schizophrenia and autism. Recently, Girirajan and Eichler (2010) offered an alternative formulation, in which phenotypes expressed in CNV carriers vary, with autism, schizophrenia, and other syndromal outcomes such as epilepsy or intellectual disability being among the possible outcomes arising from the neurodevelopmental impacts of CNVs. In that model, autism and schizophrenia represent specific instances of the variable expressivity of a common genomic disposition.
Our results should be interpreted in light of several important limitations. One such limitation is the use of a cross-sectional design; future study of these two risk groups using a longitudinal design would allow for the examination of multiple factors, including changes in the relationship between autistic features and prodromal symptoms across the risk period, associations between autistic features and conversion to psychosis, and differences in the relationship between autistic features and prodromal symptoms between those who go on to convert to psychosis and those who do not. Allowing for the study of individuals as they fully cross through the risk period for psychosis would greatly enhance our understanding of each of these important issues. Additionally, while the exclusion of individuals with Axis I disorders allowed for the study of the complex relationship between ASD and SSD in those possibly at risk for either disorder, this exclusion reduced symptom variance and precluded the investigation of these relationships among individuals with a fuller range of psychopathology. Thus, the current results are not generalizable to other 22q11DS individuals who have been diagnosed with Axis I disorders.
Lack of age-and sex-matching is potentially another limitation of the study, and future studies should attempt to employ more rigorous matching methods to ensure that similarities or differences between risk groups are not due to sociodemographic differences. Additionally, the significant communication deficits (assessed by parent or guardian self-report) found in the 22q11DS sample may have interfered with accurate assessment of current prodromal symptoms (assessed by participant self-report). Finally, given differences in assessing cognitive functioning across the SPD and 22q11DS samples, potential differences in cognitive deficits and their relationship to both prodromal symptoms and autistic features were not examined. This is a potential limitation of the study in that the two risk groups may differ with respect to deficits in various cognitive domains; further, potential differences in cognitive functioning may explain variation in symptomology. Future research with SPD and 22q11DS samples should prioritize assessment of cognitive functioning and control for potential group differences.
The present study examined autistic features and prodromal symptoms in two groups, both of which show increased risk for autistic-like behaviors and psychosis. The results add to the growing body of literature that has attempted to further clarify possible developmental and genetic relationships between autistic-like and psychotic symptoms. As discussed above, autism and schizophrenia have been shown to overlap phenomenologically, which may relate to shared etiologic factors. It has been hypothesized that the disorders overlap because susceptibility genes, although distinct, are located within the same region, highlighting the potential relevance of linkage disequilibrium (Esterberg et al., 2008) . Continued study of risk for autism and schizophrenia-spectrum disorders in 22q11DS and SPD has the potential to elucidate and refine important diagnostic predictors as well as guide intervention efforts.
